The following information is obtained from various newswires,
published medical journal articles, and medical conference presentations.
Company: Wallace Laboratories
Approval Status: Approved November 1996
Treatment for: seasonal allergic rhinitis
General Information
Astelin nasal spray has been approved for the treatment of symptoms associated with seasonal allergic rhinitis.
It offers a valuable treatment option for the estimated 20-40 million Americans who suffer from seasonal allergic rhinitis, the fifth most common chronic illness that causes millions of lost work days and significant discomfort for the sufferer.